SREBP-dependent lipidomic reprogramming as a broad-spectrum antiviral target

Nature Communications

Volumn 10, Issue 1, 2019, Pages

  Yuan, Shuofeng ^a,b   Chu, Hin ^a,b   Chan, Jasper Fuk Woo ^a,b,c,d   Ye, Zi Wei ^b   Wen, Lei ^b   Yan, Bingpeng ^b   Lai, Pok Man ^b   Tee, Kah Meng ^b   Huang, Jingjing ^b   Chen, Dongdong ^b   Li, Cun ^b   Zhao, Xiaoyu ^b   Yang, Dong ^b   Chiu, Man Chun ^b   Yip, Cyril ^b   Poon, Vincent Kwok Man ^b   Chan, Chris Chung Sing ^b   Sze, Kong Hung ^a,b   Zhou, Jie ^a,b   Chan, Ivy Hau Yee ^b   Kok, Kin Hang ^a,b   To, Kelvin Kai Wang ^a,b,c   Kao, Richard Yi Tsun ^a,b   Lau, Johnson Yiu Nam ^b   Jin, Dong Yan ^b   Perlman, Stanley ^e,f   Yuen, Kwok Yung ^a,b,c,d   more..

^a THE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c THE UNIVERSITY OF HONG KONG SHENZHEN HOSPITAL   (China)

^d HAINAN MEDICAL UNIVERSITY   (China)

^e UNIVERSITY OF IOWA   (United States)

^f GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

4 [(5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL)CARBOXAMIDO]BENZOIC ACID; ANTIVIRUS AGENT; STEROL REGULATORY ELEMENT BINDING PROTEIN; VIRAL PROTEIN; BENZOIC ACID; LIPID; PROTEIN BINDING; RETINOID; TETRALIN DERIVATIVE;

ANTIVIRAL ACTIVITY; ARTICLE; CLICK CHEMISTRY; DRUG PROTEIN BINDING; IMMUNE RESPONSE; IN VITRO STUDY; INFLUENZA A VIRUS; LIPID METABOLISM; LIPIDOMICS; LIPOGENESIS; MEMBRANE VESICLE; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; NONHUMAN; PALMITOYLATION; TRANSACTIVATION; VIRUS INFECTION; VIRUS REPLICATION; BIOSYNTHESIS; CHEMISTRY; DRUG EFFECT; METABOLISM; PHYSIOLOGY; VIROLOGY;

ANTIVIRAL AGENTS; BENZOATES; BIOSYNTHETIC PATHWAYS; INFLUENZA A VIRUS; LIPID METABOLISM; LIPIDS; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; PROTEIN BINDING; RETINOIDS; STEROL REGULATORY ELEMENT BINDING PROTEINS; TETRAHYDRONAPHTHALENES; VIRUS DISEASES; VIRUS REPLICATION;

EID: 85059829725     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-018-08015-x     Document Type: Article

References (67)

1. Lozano, R. et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2095–2128 (2012)
2. Peiris, J. S. et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361, 1319–1325 (2003)
3. Chan, J. F., Lau, S. K., Cheng, K. K., Woo, V. C. & Yuen, P. C. KY. Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin. Microbiol. Rev. 28, 465–522 (2015)
4. Yuen, K. Y. et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 351, 467–471 (1998)
5. To, K. K., Chan, J. F., Chen, H., Li, L. & Yuen, K. Y. The emergence of influenza A H7N9 in human beings 16 years after influenza A H5N1: a tale of two cities. Lancet Infect. Dis. 13, 809–821 (2013)
6. Cheng, V. C., To, K. K., Tse, H., Hung, I. F. & Yuen, K. Y. Two years after pandemic influenza A/2009/H1N1: what have we learned? Clin. Microbiol. Rev. 25, 223–263 (2012)
7. Huang, P. N. & Shih, S. R. Update on enterovirus 71 infection. Curr. Opin. Virol. 5, 98–104 (2014)
8. Musso, D. & Gubler, D. J. Zika virus. Clin. Microbiol. Rev. 29, 487–524 (2016)
9. Zumla, A., Chan, J. F., Azhar, E. I., Hui, D. S. & Yuen, K. Y. Coronaviruses - drug discovery and therapeutic options. Nat. Rev. Drug. Discov. 15, 327–347 (2016)
10. Simmons, G. et al. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc. Natl. Acad. Sci. USA 102, 11876–11881 (2005)
11. Kaletsky, R. L., Simmons, G. & Bates, P. Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivity. J. Virol. 81, 13378–13384 (2007)
12. Warren, T. K. et al. Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430. Nature 508, 402–405 (2014)
13. Altan-Bonnet, N. Lipid tales of viral replication and transmission. Trends Cell Biol. 27, 201–213 (2017)
14. Munger, J. et al. Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy. Nat. Biotechnol. 26, 1179 (2008)
15. Horton, J. D., Goldstein, J. L. & Brown, M. S. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109, 1125–1131 (2002)
16. Okuda, S. et al. KEGG Atlas mapping for global analysis of metabolic pathways. Nucleic Acids Res. 36, W423–W426 (2008)
17. De Gottardi, A., Spahr, L., Ravier-Dall’Antonia, F. & Hadengue, A. Cannabinoid receptor 1 and 2 agonists increase lipid accumulation in hepatocytes. Liver. Int. 30, 1482–1489 (2010)
18. Zhou, J. et al. Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus. Sci. Adv. 3, eaao4966 (2017)
19. Dimitrova, B., Caccia, S., Garattini, E. & Guiso, G. Determination of the retinobenzoic acid derivative Am580 in rat plasma by high-performance liquid chromatography. J. Chromatogr. B Biomed. Appl. 667, 301–306 (1995)
20. Zheng, B. J. et al. Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus. Proc. Natl. Acad. Sci. USA 105, 8091–8096 (2008)
21. Goldstein, J. L., DeBose-Boyd, R. A. & Brown, M. S. Protein sensors for membrane sterols. Cell 124, 35–46 (2006)
22. Tang, J. J. et al. Inhibition of SREBP by a small molecule, betulin, improves hyperlipidemia and insulin resistance and reduces atherosclerotic plaques. Cell Metab. 13, 44–56 (2011)
23. Yoshikawa, T. et al. Identification of liver X receptor-retinoid X receptor as an activator of the sterol regulatory element-binding protein 1c gene promoter. Mol. Cell. Biol. 21, 2991–3000 (2001)
24. Parraga, A., Bellsolell, L., Ferre-D’Amare, A. R. & Burley, S. K. Co-crystal structure of sterol regulatory element binding protein 1a at 2.3 A resolution. Structure 6, 661–672 (1998)
25. Lee, S. J. et al. The structure of importin-beta bound to SREBP-2: nuclear import of a transcription factor. Science 302, 1571–1575 (2003)
26. Oudshoorn, D. et al. Expression and cleavage of Middle East respiratory syndrome Coronavirus nsp3-4 polyprotein induce the formation of double-membrane vesicles that mimic those associated with Coronaviral RNA replication. MBio 8, pii: e01658-17 (2017)
27. Veit, M., Serebryakova, M. V. & Kordyukova, L. V. Palmitoylation of influenza virus proteins. Biochem. Soc. Trans. 41, 50–55 (2013)
28. Webb, Y., Hermida-Matsumoto, L. & Resh, M. D. Inhibition of protein palmitoylation, raft localization, and T cell signaling by 2-bromopalmitate and polyunsaturated fatty acids. J. Biol. Chem. 275, 261–270 (2000)
29. Adams, C. M. et al. Cholesterol and 25-hydroxycholesterol inhibit activation of SREBPs by different mechanisms, both involving SCAP and Insigs. J. Biol. Chem. 279, 52772–52780 (2004)
30. Blanc, M. et al. The transcription factor STAT-1 couples macrophage synthesis of 25-hydroxycholesterol to the interferon antiviral response. Immunity 38, 106–118 (2013)
31. Kaur, G. & Dufour, J. M. Cell lines: valuable tools or useless artifacts. Spermatogenesis 2, 1–5 (2012)
32. Ivanova, P. T., Milne, S. B., Byrne, M. O., Xiang, Y. & Brown, H. A. Glycerophospholipid identification and quantitation by electrospray ionization mass spectrometry. Methods Enzymol. 432, 21–57 (2007)
33. Petersen, J. et al. The major cellular sterol regulatory pathway is required for Andes virus infection. PLoS Pathog. 10, e1003911 (2014)
34. Kleinfelter, L. M. et al. Haploid genetic screen reveals a profound and direct dependence on cholesterol for Hantavirus membrane fusion. mBio 6, e00801 (2015)
35. Munger, J. et al. Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy. Nat. Biotechnol. 26, 1179–1186 (2008)
36. Heaton, N. S. et al. Dengue virus nonstructural protein 3 redistributes fatty acid synthase to sites of viral replication and increases cellular fatty acid synthesis. Proc. Natl. Acad. Sci. USA 107, 17345–17350 (2010)
37. Arafa, H. M. et al. Selective agonists of retinoic acid receptors: comparative toxicokinetics and embryonic exposure. Arch. Toxicol. 73, 547–556 (2000)
38. Miwako, I. & Kagechika, H. Tamibarotene. Drugs Today (Barc) 43, 563–568 (2007)
39. Chan, J. F. et al. Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: implications for disease pathogenesis and clinical manifestation. J. Infect. Dis. 207, 1743–1752 (2013)
40. Zhou, J. et al. Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis. J. Infect. Dis. 209, 1331–1342 (2014)
41. Kao, R. Y. et al. Identification of influenza A nucleoprotein as an antiviral target. Nat. Biotechnol. 28, 600–605 (2010)
42. Chu, H. et al. Middle East respiratory syndrome Coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways. J. Infect. Dis. 213, 904–914 (2016)
43. Yeung, M. L. et al. MERS coronavirus induces apoptosis in kidney and lung by upregulating Smad7 and FGF2. Nat. Microbiol 1, 16004 (2016)
44. Kim, D., Langmead, B. & Salzberg, S. L. HISAT: a fast spliced aligner with low memory requirements. Nat. Methods 12, 357–360 (2015)
45. Langmead, B., Trapnell, C., Pop, M. & Salzberg, S. L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10, R25 (2009)
46. Young, M. D., Wakefield, M. J., Smyth, G. K. & Oshlack, A. Gene ontology analysis for RNA-seq: accounting for selection bias. Genome Biol. 11, R14 (2010)
47. Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27–30 (2000)
48. Sze, K. H. et al. Talaromyces marneffei Mp1p is a virulence factor that binds and sequesters a key proinflammatory lipid to dampen host innate immune response. Cell Chem. Biol. 24, 182–194 (2017)
49. Burnum-Johnson, K. E. et al. MPLEx: a method for simultaneous pathogen inactivation and extraction of samples for multi-omics profiling. Analyst 142, 442–448 (2017)
50. Nakayasu, E. S. et al. MPLEx: a robust and universal protocol for single-sample integrative proteomic, metabolomic, and lipidomic analyses. Msystems 1, pii: e00043-16 (2016)
51. Tsugawa, H. et al. MS-DIAL: data-independent MS/MS deconvolution for comprehensive metabolome analysis. Nat. Methods 12, 523–526 (2015)
52. Kind, T. et al. LipidBlast in silico tandem mass spectrometry database for lipid identification. Nat. Methods 10, 755–758 (2013)
53. Silva, L. P. et al. Measurement of DNA concentration as a normalization strategy for metabolomic data from adherent cell lines. Anal. Chem. 85, 9536–9542 (2013)
54. Chong, J. et al. MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis. Nucleic Acids Res. 46, W486–w494 (2018)
55. Zhu, Z. J. et al. Liquid chromatography quadrupole time-of-flight mass spectrometry characterization of metabolites guided by the METLIN database. Nat. Protoc. 8, 451–460 (2013)
56. Xia, J. & Wishart, D. S. Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst. Nat. Protoc. 6, 743 (2011)
57. Chan, J. F. et al. Novel antiviral activity and mechanism of bromocriptine as a Zika virus NS2B-NS3 protease inhibitor. Antivir. Res. 141, 29–37 (2017)
58. Agostini M. L., et al. Coronavirus susceptibility to the antiviral Remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease. MBio 9, e00221-18 (2018)
59. Furuta, Y. et al. Favipiravir (T-705), a novel viral RNA polymerase inhibitor. Antivir. Res. 100, 446–454 (2013)
60. Yuan, S. et al. A novel small-molecule compound disrupts influenza A virus PB2 cap-binding and inhibits viral replication. J. Antimicrob. Chemother, 71, 2489–2497 (2016)
61. Yuan, S. et al. Identification of a small-molecule inhibitor of influenza virus via disrupting the subunits interaction of the viral polymerase. Antivir. Res. 125, 34–42 (2016)
62. Chan, C. M. et al. Carcinoembryonic antigen-related cell adhesion molecule 5 is an important surface attachment factor that facilitates entry of Middle East respiratory syndrome Coronavirus. J. Virol. 90, 9114–9127 (2016)
63. Yang, J. et al. The I-TASSER Suite: protein structure and function prediction. Nat. Methods 12, 7–8 (2015)
64. Sastry, G. M., Adzhigirey, M., Day, T., Annabhimoju, R. & Sherman, W. Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J. Comput. Aided Mol. Des. 27, 221–234 (2013)
65. Kim, S. et al. PubChem substance and compound databases. Nucleic Acids Res. 44, D1202–D1213 (2016)
66. Stroganov, O. V., Novikov, F. N., Stroylov, V. S., Kulkov, V. & Chilov, G. G. Lead finder: an approach to improve accuracy of protein-ligand docking, binding energy estimation, and virtual screening. J. Chem. Inf. Model. 48, 2371–2385 (2008)
67. Woo, P. C. et al. Feline morbillivirus, a previously undescribed paramyxovirus associated with tubulointerstitial nephritis in domestic cats. Proc. Natl. Acad. Sci. USA 109, 5435–5440 (2012)